全文获取类型
收费全文 | 60241篇 |
免费 | 4562篇 |
国内免费 | 2119篇 |
专业分类
耳鼻咽喉 | 382篇 |
儿科学 | 1409篇 |
妇产科学 | 740篇 |
基础医学 | 8989篇 |
口腔科学 | 791篇 |
临床医学 | 4594篇 |
内科学 | 9417篇 |
皮肤病学 | 1160篇 |
神经病学 | 4802篇 |
特种医学 | 860篇 |
外国民族医学 | 11篇 |
外科学 | 4442篇 |
综合类 | 6395篇 |
现状与发展 | 10篇 |
预防医学 | 4916篇 |
眼科学 | 995篇 |
药学 | 10332篇 |
8篇 | |
中国医学 | 3064篇 |
肿瘤学 | 3605篇 |
出版年
2023年 | 872篇 |
2022年 | 1493篇 |
2021年 | 1909篇 |
2020年 | 1807篇 |
2019年 | 2388篇 |
2018年 | 2342篇 |
2017年 | 1976篇 |
2016年 | 1899篇 |
2015年 | 2098篇 |
2014年 | 3276篇 |
2013年 | 4014篇 |
2012年 | 3399篇 |
2011年 | 4053篇 |
2010年 | 3380篇 |
2009年 | 2793篇 |
2008年 | 2643篇 |
2007年 | 2480篇 |
2006年 | 2101篇 |
2005年 | 1833篇 |
2004年 | 1634篇 |
2003年 | 1510篇 |
2002年 | 1241篇 |
2001年 | 1088篇 |
2000年 | 832篇 |
1999年 | 849篇 |
1998年 | 697篇 |
1997年 | 646篇 |
1996年 | 556篇 |
1995年 | 487篇 |
1994年 | 437篇 |
1993年 | 409篇 |
1992年 | 371篇 |
1991年 | 348篇 |
1990年 | 306篇 |
1989年 | 247篇 |
1988年 | 243篇 |
1986年 | 183篇 |
1985年 | 806篇 |
1984年 | 1036篇 |
1983年 | 821篇 |
1982年 | 941篇 |
1981年 | 888篇 |
1980年 | 662篇 |
1979年 | 619篇 |
1978年 | 444篇 |
1977年 | 356篇 |
1976年 | 408篇 |
1975年 | 311篇 |
1974年 | 193篇 |
1973年 | 196篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
101.
D. M. Wolf R. Rokicka-Milewska† S. Lopaciuk† A. B. Skotnicki§ A. Klukowska† P. Laguna† J. Windyga‡ R. Kotitschke W. G. Struff 《Haemophilia》2004,10(5):438-448
Clinical efficacy, safety and pharmacokinetic properties of the high-purity double-virus inactivated plasma-derived factor VIII concentrate Haemoctin SDH (pdFVIII) were evaluated in three prospective open-label uncontrolled studies in previously treated patients (PTPs) with severe haemophilia A. The pharmacokinetic properties assessed at baseline and after 3 months of treatment are in accurate accordance with published data and remain unchanged over time (study A, n = 12). Mean terminal elimination half-life was 11.8 and 11.9 h, mean incremental recovery (IU dL(-1)/IU kg(-1)) was 2.3 and 2.0, respectively. Long-term efficacy and safety, in particular the potential immunogenicity, were investigated in a total of 53 PTPs (studies A and B) treated prophylactically and on-demand, as required. PdFVIII has shown to be effective in preventing and controlling bleeding episodes; 23.5% of patients were free of bleeding events. A total of 177 haemorrhages occurred with 74.0% resolving after a single infusion, 87.6% within two infusions. 98.3% of responses reported on haemorrhages were rated as 'excellent' or 'good'. Moreover, 'excellent' haemostatic efficacy has been demonstrated in 10 surgical procedures including general and severe orthopaedic interventions (study C). No complication occurred in any surgery. Few adverse events were reported, one patient developed a high-titre FVIII inhibitor without clinical relevance. In all three studies, over 6 million units were administered in nearly 4300 infusions, approximately 94% units or infusions were given for prophylaxis and only 6% for treatment on-demand. In conclusion, pdFVIII has shown to be effective, safe and well tolerated in long-term prophylaxis and treatment on-demand as well as after minor and major surgical procedures. 相似文献
102.
Early multiple organ dysfunction syndrome appears to be facilitated with bacterial translocation in severely burn injury, yet the mechanisms of bacterial translocation remains in dispute. The aim of this study was to investigate the potential role of intestinal bifidobacteria in the pathogenesis of gut-derived bacteria/endotoxin translocation following burns and the effects of bifidobacterial supplement on gut barrier. Methods: Wistar rats were randomly divided into burn group (Burn, n=60),sham burn group (SB, n=10) in experiment Ⅰ , and burn + saline group (BS, n=30), burn + bifidobacteria group (BB, n=30), and sham-burn + saline group (SS, n= 10) in experiment Ⅱ. Animals in BB group were fed bifidobacterial preparation (5 × 109 CFU/ml) after burns, 1.5ml,twice daily. Animals in BS and SS were fed saline. Samples were taken on days 1, 3, and 5 in burn groups, and on day 3 in sham-burn groups. The incidence of bacteria/endotoxin translocation and counts of Bifidobacterium, Fungi and Escherichia coli in gut mucosa were determined with standard methods. The levels of sIgA in mucus of small intestine were measured by RIA. The positive sIgA expression in lamina propria and ileum mucosal injury was evaluated light microscopically by blinded examiners. Results: Our results showed that the incidence of bacterial translocation was increased after burns, which was accompanied by significant decrease in number of bifidobacteria but significant increase in E. coli and fungi in gut mucosa, and elevation of levels of plasma endotoxin and IL-6 (P<0. 001).The incidence of bacterial translocation was markedly reduced after 3- and 5-day supplementation of bifidobacteria compared with control group (P<0.05). The counts of mucosal bifidobacteria were increased by 4- to 40-fold,while E. coli and fungi were decreased by 2- to 30-fold and 10- to 150-fold, respectively, after bifidobacterial supplementation in contrast to control group. The damage of mucosa tended to be less pronounced after 3-day bifidobacteria-supplemented formula compared with control group [grade 2(0-6) vs. grade 4(3-6), P<0.05]. Moreover, the expression and release of sIgA was markedly augmented after 3-day bifidobacteria-supplementation formula and it returned to normal range on day 5. Conclusion: The decrease in counts and proportion of bifidobacteria in mucous membrane flora may play an important role in the development of bacteria/endotoxin translocation following thermal injury. The supplement of exogenous bifidobacteria could per se improve gut barriers, and attenuate bacteria/endotoxin translocation secondary to major burns. 相似文献
103.
目的我们前期的实验结果显示A20 mRNA和蛋白在人脑胶质瘤组织及细胞系(U251、U87、BT325)中高表达,本研究拟构建A20RNAi载体,并检测其对U251细胞A20表达的抑制作用。方法构建三种针对人A20基因的真核干涉表达载体,以脂质体法将其分别转染人脑胶质瘤细胞系U251,以RT-PCR、蛋白印迹法检测各干涉载体对U251细胞中A20mRNA和蛋白表达的抑制作用。结果成功构建三种针对A20基因的RNAi载体,经RT-PCR、蛋白印迹检测筛选出对A20基因干涉效果最佳的载体,命名为pSilencer3.1-A20R1。结论成功构建A20基因干涉载体,为进一步探讨A20与脑胶质瘤恶性增殖、血管形成以及抗凋亡的关系奠定实验基础。 相似文献
104.
目的:研究蛇毒Ⅱ类磷脂酶A2(PLA2)中D49 PLA2和K49 PLA2的功能分化及其功能分化决定位点的鉴定。方法:运用序列比较分析,进化树构建和DIVERGE v1.04软件计算研究D49 PLA2和K49 PLA2的功能分化情况及其分化位点。结果:序列比较分析,进化树构建和DIVERGE v1.04软件计算结果表明蛇毒Ⅱ类PLA2中D49 PLA2和K49 PLA2的确发生了功能分化,对于K49 PLA2来说,1S,7K,11Q,E12,R34,T56,N88,L92,E108,K116,K128可能为功能分化决定位点。对于D49 PLA2,L2,G33,G35,F46和Y118可能为功能分化决定位点。结论:我们首次通过序列比较分析,进化树构建和DIVERGE v1.04软件计算鉴定出蛇毒Ⅱ类PLA2中D49 PLA2和K49 PLA2可能的功能分化位点,为今后通过基因重组和定点突变方法研究蛇毒Ⅱ类PLA2结构功能关系提供了线索。 相似文献
105.
幽门螺杆菌感染及其毒力因子和胃十二指肠疾病关系的研究 总被引:9,自引:0,他引:9
目的 探讨幽门螺杆菌(Hp)感染病人中Hp细胞毒相关蛋白(CagA)、细胞空泡毒素(VacA)抗体在胃十二指肠疾病的比例,并评估不同类型幽门螺杆菌感染对胃窦粘膜炎症程度的影响。方法 应用免疫印迹法测定Hp感染者病人体内的CagA、VacA抗体。结果 73%的Hp感染者病人中出现CagA抗体,61%Hp感染者病人中出现VacA抗体。CagA抗体和VacA抗体在各疾病之间差异无显著性(P>0.05)。在胃溃疡、十二指肠溃疡和复合性溃疡三类病人中,具CagA和VacA双阳性的比例较CagA和VacA双阴性的比例差异有显著性(P<0.05)。胃窦萎缩病变在CagA和VacA双阳性的病人中比CagA和VacA双阴性的病人严重(P<0.05)。结论 具有高毒力因子(CagA和VacA)的Hp是胃肠疾病病人感染的常见菌株,具有CagA和VacA的Hp可能在诱导胃粘膜发展到萎缩病变过程中起重要作用。但不能作为特异性指标来判断胃十二指肠疾病。 相似文献
106.
J. K. Brown P. A. Knight S. H. Wright E. M. Thornton H. R. P. Miller 《Clinical and experimental allergy》2003,33(1):132-146
BACKGROUND: The mucosal mast cell (MMC) granule-specific beta-chymase, mouse mast cell protease-1 (mMCP-1), is released systemically into the bloodstream early in nematode infection before parasite-specific IgE responses develop and TGF-beta1 induces constitutive release of mMCP-1 by homologues of MMC in vitro. Intraepithelial MMC may also express the chemokine CCL2 (monocyte chemotactic protein-1) during nematode infection but the expression of this chemokine by MMC homologues has not been investigated. OBJECTIVE: To investigate the expression and to compare the mechanisms of constitutive release of the chymase, mMCP-1, and the chemokine, CCL2. METHODS: MMC homologues were generated by culturing bone marrow cells in the presence of TGF-beta1, IL-3, IL-9 and stem cell factor (SCF). The intracellular distribution of mMCP-1 and CCL2 was examined by confocal microscopy. The involvement of the Golgi complex and of protein synthesis in the constitutive release of mMCP-1 and CCL2 was investigated using the Golgi-disrupting agent brefeldin A and cycloheximide to block protein synthesis. Secreted analytes were quantified by ELISA. RESULTS: mMCP-1 colocalized with Golgi matrix protein 130 but was most abundant in the granules, whereas CCL2 was not found in the granules but appeared to be located uniquely in the Golgi complex. Extracellular release of mMCP-1 was significantly inhibited ( approximately 40%) by cycloheximide and by the Golgi-disrupting agent brefeldin A, indicating both continuous protein synthesis and transportation via the Golgi complex are required for optimal mMCP-1 secretion. A similar but more marked inhibitory effect with both compounds was demonstrated on the constitutive secretion of CCL2. CONCLUSION: The culture conditions that promote mMCP-1 expression and release by MMC homologues also promote the expression and release of CCL2. Constitutive release involves de novo protein synthesis and requires a functional Golgi complex, suggesting that similar mechanisms of extracellular secretion operate for both mediators. 相似文献
107.
高效液相色谱法测定石杉碱甲片的含量 总被引:2,自引:0,他引:2
采用高效液相色谱法测定石杉碱甲片的含量。固定相为μBondapak C18,流动相为乙腈-0.02mol/L磷酸二氢钾溶液(12:88),以对乙酰氨基酚为内标,石杉碱甲浓度在10 ̄50mg/L范围内与峰面积呈良好的线性关系,平均回收率为99.93%,RSD为0.41%(n=9)。 相似文献
108.
观察硒和维生素A(VA)对支原体肺炎的治疗效果.方法 采用双盲随机对照2×2析因实验设计,选择100例住院支原体肺炎患儿,分为补硒组26例,补VA组23例,补硒和VA组30例以及病例对照组21例,正常组21例.一次补硒量为1mg亚硒酸钠和/或15万单位VA,对照病例组给予常规治疗.结果 与对照组比,治疗后3个补充组的症状和体征缓解天数均有不同程度缩短(P<0.05),补硒组白细胞硒和谷胱甘肽过氧化物酶水平显著上升(P<0.05),补VA、补硒组血清VA水平上升(P<0.01),细胞免疫功能有所改善.结论 硒和VA有协同作用,补充硒或同时加VA,作为辅助治疗支原体肺炎的方法,安全、有效. 相似文献
109.
Association of angiotensin II type 1 receptor gene polymorphism with essential hypertension 总被引:15,自引:0,他引:15
The renin-angiotensin system is involved in control of blood pressure and salt and fluid homeostasis. Genes for components of this system have been of major focus in research on the causation of the common, complex, polygenic trait, essential hypertension (HT). Association of an A→C variant at nucleotide 1166 of the angiotensin II type 1 receptor (AT1 R) gene with HT, but an absence of linkage of this locus with this disease, has been reported recently. Since confirmation in a different setting is imperative, we performed a cross-sectional case-control study of the A1166C variant in a well-characterized group of 108 Caucasian HT subjects with a strong family history (two affected parents) and early onset disease. Genotyping was by mismatch polymerase chain reaction/ Bfr I restriction fragment length polymorphism analysis. Frequency of the C1166 allele was 0.40 in HTs and 0.29 in normotensives. The difference in genotype (χ2 = 13, P = 0.0015) and allele (χ2 = 5.3, P = 0.02) frequencies between the two groups was significant (odds ratio for CC vs AA+AC = 7.3 [95% CI, 1.9–31.9). The present results implicate the AT1 R gene, or a locus in linkage disequilibrium with the variant tested, in the causation of essential HT. 相似文献
110.
人体β-胡萝卜素的肠转化和吸收后转化的研究 总被引:5,自引:1,他引:4
目的 :为了解部分中国人体内 β 胡萝卜素 ( β carotene ,以下简称 β C)转化维生素A (vitaminA ,以下简称VA)的效率 ,开展了本研究。方法 :使用稳定同位素稀释法对 15名 5 0 60岁健康农村志愿者 (男 9,女6)进行β C人体代谢实验。 2周适应期和 5 6天实验期内 ,志愿者接受常规膳食 ,避免大量VA和 β C摄入以及烟、酒和营养补充剂。实验第 1天 ,给受试者含 6mg氘标记 β C( 2 H8β C)玉米油胶丸 ,随半流质早餐 (脂肪热能比 2 5 % )一起摄入。实验第 4天 ,受试者以同样方法摄入含 3mg氘标记醋酸视黄醇 ( 2 H8RAC)油剂胶丸。实验第 1天和第 4天摄入标记物后 0 ,3 ,5 ,7,9,11,13h时 ,实验第 2 ,3 ,5 ,6,7,8,9,10 ,14,2 1,2 8,3 5 ,42 ,49,5 6天晨空腹时 ,采静脉血。用高效液相色谱仪 (HPLC)分离血清 β C和VA组分 ,再分别使用气相质谱仪(GC MS)和液相质谱仪 (LC MS)测定VA和 β C组分的同位素丰度。根据VA和 β C的浓度和同位素丰度 ,描述标记VA和β C在体内应答的血液动力学曲线。 结果 :所有 15名受试者对2 H8RAC应答明显 ;但是在对2 H8β C的应答方面 ,只有 11名受试者2 H4视黄醇应答曲线明显 ,有 4名受试者血清2 H4视黄醇应答曲线非常微弱。经过对备份血清样品进行的多次重复GC MS测定 ,我们目前初步? 相似文献